Pasar al contenido principal

INTEGRANDO LAS MODIFICACIONES POSTRADUCCIONALES ESPECIFICAS DE SITIO EN ENFERMEDADES CONFORMACIONALES: MECANISMOS, EVOLUCION Y TERAPIAS

RTI2018-096246-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The catalytic cycle of the antioxidant and cancer-associated human NQO1 enzyme: hydride transfer, conformational dynamics and functional cooperativity

  • Anoz-Carbonell, E.
  • Timson, David J.
  • Pey, Ángel L.
  • Medina, Milagros
22 pags., 9 figs., 3 tabs. -- This article belongs to the Special Issue Antioxidants and Cancer, Human NQO1 [NAD(H):quinone oxidoreductase 1] is a multi-functional and stress-inducible dimeric protein involved in the antioxidant defense, the activation of cancer prodrugs and the stabilization of oncosuppressors. Despite its roles in human diseases, such as cancer and neurological disorders, a detailed characterization of its enzymatic cycle is still lacking. In this work, we provide a comprehensive analysis of the NQO1 catalytic cycle using rapid mixing techniques, including multiwavelength and spectral deconvolution studies, kinetic modeling and temperature-dependent kinetic isotope effects (KIEs). Our results systematically support the existence of two pathways for hydride transfer throughout the NQO1 catalytic cycle, likely reflecting that the two active sites in the dimer catalyze two-electron reduction with different rates, consistent with the cooperative binding of inhibitors such as dicoumarol. This negative cooperativity in NQO1 redox activity represents a sort of half-of-sites activity. Analysis of KIEs and their temperature dependence also show significantly different contributions from quantum tunneling, structural dynamics and reorganizations to catalysis at the two active sites. Our work will improve our understanding of the effects of cancer-associated single amino acid variants and post-translational modifications in this protein of high relevance in cancer progression and treatment., This research was funded by the ERDF/Spanish Ministry of Science, Innovation and Universities—State Research Agency (Grant RTI2018-096246-B-I00, to A.L.P.), Spanish Ministry of Science and Innovation—State Research Agency (Grant PID2019-103901GB-I00, to M.M.), Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía (Grants P11-CTS-07187 and P18-RT-2413, to A.L.P.) and Gobierno de Aragon-FEDER (Grant E35_20R), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modular droplet injector for sample conservation providing new structural insight for the conformational heterogeneity in the disease-associated NQO1 enzyme

  • Doppler, Diandra
  • Sonker, Mukul
  • Egatz-Gomez, Ana
  • Grieco, Alice
  • Zaare, Sahba
  • Jernigan, Rebecca
  • Meza-Aguilar, Jose Domingo
  • Rabbani, Mohammad T.
  • Manna, Abhik
  • Alvarez, Roberto C.
  • Karpos, Konstantinos
  • Cruz Villarreal, Jorvani
  • Nelson, Garrett
  • Yang, Jay-How
  • Carrion, Jackson
  • Morin, Katherine
  • Ketawala, Gihan K
  • Pey, Angel L.
  • Ruiz-Fresneda, Miguel A.
  • Pacheco-García, Juan Luis
  • Hermoso, Juan A.
  • Nazari, Reza
  • Sierra, Raymond
  • Hunter, Mark S.
  • Batyuk, Alexander
  • Kupitz, Christopher J.
  • Sublett, Robert E.
  • Lisova, Stella
  • Mariani, Valerio
  • Boutet, Sébastien
  • Fromme, Raimund
  • Grant, Thomas D.
  • Botha, Sabine
  • Fromme, Petra
  • Kirian, Richard A.
  • Martín-García, José M.
  • Ros, Alexandra
18 pags. 7 figs., 1 tab. -- This article is part of the themed collection: Lab on a Chip HOT Articles 2023, Droplet injection strategies are a promising tool to reduce the large amount of sample consumed in serial femtosecond crystallography (SFX) measurements at X-ray free electron lasers (XFELs) with continuous injection approaches. Here, we demonstrate a new modular microfluidic droplet injector (MDI) design that was successfully applied to deliver microcrystals of the human NAD(P)H:quinone oxidoreductase 1 (NQO1) and phycocyanin. We investigated droplet generation conditions through electrical stimulation for both protein samples and implemented hardware and software components for optimized crystal injection at the Macromolecular Femtosecond Crystallography (MFX) instrument at the Stanford Linac Coherent Light Source (LCLS). Under optimized droplet injection conditions, we demonstrate that up to 4-fold sample consumption savings can be achieved with the droplet injector. In addition, we collected a full data set with droplet injection for NQO1 protein crystals with a resolution up to 2.7 Å, leading to the first room-temperature structure of NQO1 at an XFEL. NQO1 is a flavoenzyme associated with cancer, Alzheimer's and Parkinson's disease, making it an attractive target for drug discovery. Our results reveal for the first time that residues Tyr128 and Phe232, which play key roles in the function of the protein, show an unexpected conformational heterogeneity at room temperature within the crystals. These results suggest that different substates exist in the conformational ensemble of NQO1 with functional and mechanistic implications for the enzyme's negative cooperativity through a conformational selection mechanism. Our study thus demonstrates that microfluidic droplet injection constitutes a robust sample-conserving injection method for SFX studies on protein crystals that are difficult to obtain in amounts necessary for continuous injection, including the large sample quantities required for time-resolved mix-and-inject studies., Financial support from the STC Program of the National Science Foundation through BioXFEL (under agreement # 1231306), ABI Innovations award (NSF # 1565180), IIBR award (# 1943448), MCB award (1817862), and the National Institutes of Health award # R01GM095583 is gratefully acknowledged. The use of the Linac Coherent Light Source (LCLS), SLAC National Accelerator Laboratory, is generously supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract # DE-AC02-76SF00515. The authors would like to acknowledge the instrument group and facility staff for their assistance in the use of the MFX instrument during proposal MFXLW7919 at LCLS. The HERA system for in-helium experiments at MFX was developed by Bruce Doak and funded by the Max Planck Institute for Medical Research. This work was also supported by The Center for Structural Dynamics in Biology, NIH grant P41GM139687. Alice Grieco and Jose M. Martin-Garcia were supported by the “Ayuda de Atracción y Retención de Talento Investigador” from the Community of Madrid, Spain (REF: 2019-T1/BMD-15552). JLPG and ALP acknowledge funding from the ERDF/Spanish Ministry of Science, Innovation, and Universities—State Research Agency (grant RTI2018-096246-BI00), Consejería de Economía, Conocimiento, Empresas, y Universidad, Junta de Andalucía (grant P18-RT-2413), and ERDF/Counseling of Economic transformation, Industry, Knowledge, and Universities (grant B-BIO-84-UGR20)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural dynamics at the active site of the cancer-associated flavoenzyme NQO1 probed by chemical modification with PMSF

  • Grieco, Alice
  • Ruiz-Fresneda, Miguel A.
  • Gómez-Mulas, Atanasio
  • Pacheco-García, Juan Luis
  • Quereda-Moraleda, Isabel
  • Pey, Angel L.
  • Martín-García, José M.
12 pags., 4 figs., 1 tab., A large conformational heterogeneity of human NAD(P)H:quinone oxidoreductase 1 (NQO1), a flavoprotein associated with various human diseases, has been observed to occur in the catalytic site of the enzyme. Here, we report the X-ray structure of NQO1 with phenylmethylsulfonyl fluoride (PMSF) at 1.6 Å resolution. Activity assays confirmed that, despite being covalently bound to the Tyr128 residue at the catalytic site, PMSF did not abolish NQO1 activity. This may indicate that the PMSF molecule does not reduce the high flexibility of Tyr128, thus allowing NADH and DCPIP substrates to bind to the enzyme. Our results show that targeting Tyr128, a key residue in NQO1 function, with small covalently bound molecules could possibly not be a good drug discovery strategy to inhibit this enzyme., The X-ray diffraction experiments presented in this study were carried out at BL13-XALOC at ALBA syn-chrotron under proposal number 2020084437. The following funding is acknowledged: Ayuda de Atracción y Retención de Talento Investigador from the Community of Madrid (No. 2019-T1/BMD-15552); ERDF/Spanish Ministry of Science, Innovation and Universities—State Research Agency (Grant number RTI2018-096246-B-I00), Consejerıa de Economıa, Conocimiento Empresas y Universidad, Junta de Andalucía (Grant number P18-RT-2413), ERDF/Counseling of Economic transformation, Industry, Knowledge and Universities(Grant B-BIO-84-UGR20)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants

  • Vankova, Pavla
  • Pacheco-García, Juan Luis
  • Loginov, Dmitry S.
  • Gómez-Mulas, Atanasio
  • Kádek, Alan
  • Martín-García, José M.
  • Salido, Eduardo
  • Man, Petr
  • Pey, Angel L.
15 pags., 6 figs., Primary hyperoxaluria type I (PH1) is caused by deficient alanine:glyoxylate aminotransferase (AGT) activity. PH1-causing mutations in AGT lead to protein mistargeting and aggregation. Here, we use hydrogen-deuterium exchange (HDX) to characterize the wild-type (WT), the LM (a polymorphism frequent in PH1 patients) and the LM G170R (the most common mutation in PH1) variants of AGT. We provide the first experimental analysis of AGT structural dynamics, showing that stability is heterogeneous in the native state and providing a blueprint for frustrated regions with potentially functional relevance. The LM and LM G170R variants only show local destabilization. Enzymatic transamination of the pyridoxal 5-phosphate cofactor bound to AGT hardly affects stability. Our study, thus, supports that AGT misfolding is not caused by dramatic effects on structural dynamics., Access to the Structural Mass Spectrometry core facility—BioCeV was funded by the CIISB, Instruct-CZCentre, supported by MEYS CR (LM2023042). Euro-pean Regional Development Fund-Project “UPCIISB” (No. CZ.02.1.01/0.0/0.0/18_046/0015974) andEPIC-XS H2020 (823839) are gratefully acknowledged.The research of JLP-G, AG-M, and ALP was sup-ported by the ERDF/Spanish Ministry of Science,Innovation and Universities—State Research Agency(Grant RTI2018-096246-B-I00), Consejerıa de Economıa, Conocimiento, Empresas y Universidad, Junta deAndalucıa (Grant P18-RT-2413) and ERDF/Counsel-ing of Economic transformation, Industry, Knowledgeand Universities (Grant B-BIO-84-UGR20, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural dynamics and functional cooperativity of humanNQO1 by ambient temperature serial crystallography andsimulations

  • Grieco, Alice
  • Boneta, Sergio
  • Gavira Gallardo, J. A.
  • Pey, Ángel L.
  • Basu, Shibom
  • Orlans, Julien
  • Sanctis, Daniele de
  • Medina, Milagros
  • Martín-García, José M.
The human NQO1 (hNQO1) is a flavin adenine nucleotide (FAD)-dependentoxidoreductase that catalyzes the two-electron reduction of quinones to hydro-quinones, being essential for the antioxidant defense system, stabilization oftumor suppressors, and activation of quinone-based chemotherapeutics. More-over, it is overexpressed in several tumors, which makes it an attractive cancerdrug target. To decipher new structural insights into the flavin reductive half-reaction of the catalytic mechanism of hNQO1, we have carried serial crystal-lography experiments at new ID29 beamline of the ESRF to determine, to thebest of our knowledge, the first structure of the hNQO1 in complex withNADH. We have also performed molecular dynamics simulations of freehNQO1 and in complex with NADH. This is the first structural evidence thatthe hNQO1 functional cooperativity is driven by structural communicationbetween the active sites through long-range propagation of cooperative effectsacross the hNQO1 structure. Both structural results and MD simulations havesupported that the binding of NADH significantly decreases protein dynamics, The European Union NextGenerationEU/PRTR (Grant number CNS2022-135713), the MCIN/AEI/10.13039/501100011033/ERDF (Grant number MCIN/AEI/PID2022-136369NB-I00); Ayuda de Atracción y Retención de Talento Investigador from the Community of Madrid (Grant number 2019-T1/BMD-15552); ERDF/Spanish Ministry of Science, Innovation and Universities-State Research Agency (Grant number RTI2018-096246-B-I00), Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía (Grant number P18-RT-2413), ERDF/Counseling of Economic Transformation, Industry, Knowledge and Universities (Grant number B-BIO-84-UGR20), Gobierno de Aragon (Grant number E35-23R)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The catalytic cycle of the antioxidant and cancer-associated human NQO1 enzyme: Hydride transfer, conformational dynamics and functional cooperativity

  • Anoz-Carbonell, E.
  • Timson, D.J.
  • Pey, A.L.
  • Medina, M.
Human NQO1 [NAD(H):quinone oxidoreductase 1] is a multi-functional and stress-inducible dimeric protein involved in the antioxidant defense, the activation of cancer prodrugs and the stabilization of oncosuppressors. Despite its roles in human diseases, such as cancer and neurological disorders, a detailed characterization of its enzymatic cycle is still lacking. In this work, we provide a comprehensive analysis of the NQO1 catalytic cycle using rapid mixing techniques, including multiwavelength and spectral deconvolution studies, kinetic modeling and temperature-dependent kinetic isotope effects (KIEs). Our results systematically support the existence of two pathways for hydride transfer throughout the NQO1 catalytic cycle, likely reflecting that the two active sites in the dimer catalyze two-electron reduction with different rates, consistent with the cooperative binding of inhibitors such as dicoumarol. This negative cooperativity in NQO1 redox activity represents a sort of half-of-sites activity. Analysis of KIEs and their temperature dependence also show significantly different contributions from quantum tunneling, structural dynamics and reorganizations to catalysis at the two active sites. Our work will improve our understanding of the effects of cancer-associated single amino acid variants and post-translational modifications in this protein of high relevance in cancer progression and treatment.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Allosteric Communication in the Multifunctional and Redox NQO1 Protein Studied by Cavity-Making Mutations

  • Pacheco-Garcia, Juan Luis
  • Loginov, Dmitry S.
  • Anoz-Carbonell, Ernesto
  • Vankova, Pavla
  • Palomino-Morales, Rogelio
  • Salido, Eduardo
  • Man, Petr
  • Medina, Milagros
  • Naganathan, Athi N.
  • Pey, Angel L.
Allosterism is a common phenomenon in protein biochemistry that allows rapid regulation of protein stability; dynamics and function. However, the mechanisms by which allosterism occurs (by mutations or post-translational modifications (PTMs)) may be complex, particularly due to long-range propagation of the perturbation across protein structures. In this work, we have investigated allosteric communication in the multifunctional, cancer-related and antioxidant protein NQO1 by mutating several fully buried leucine residues (L7, L10 and L30) to smaller residues (V, A and G) at sites in the N-terminal domain. In almost all cases, mutated residues were not close to the FAD or the active site. Mutations L\u2192G strongly compromised conformational stability and solubility, and L30A and L30V also notably decreased solubility. The mutation L10A, closer to the FAD binding site, severely decreased FAD binding affinity (\u224820 fold vs. WT) through long-range and context-dependent effects. Using a combination of experimental and computational analyses, we show that most of the effects are found in the apo state of the protein, in contrast to other common polymorphisms and PTMs previously characterized in NQO1. The integrated study presented here is a first step towards a detailed structural-functional mapping of the mutational landscape of NQO1, a multifunctional and redox signaling protein of high biomedical relevance.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A single evolutionarily divergent mutation determines the different FAD-binding affinities of human and rat NQO1 due to site-specific phosphorylation

  • Pacheco-Garcia J.L.
  • Loginov D.
  • Rizzuti B.
  • Vankova P.
  • Neira J.L.
  • Kavan D.
  • Mesa-Torres N.
  • Guzzi R.
  • Man P.
  • Pey A.L.
The phosphomimetic mutation S82D in the cancer-associated, FAD-dependent human NADP(H):quinone oxidoreductase 1 (hNQO1) causes a decrease in flavin-adenine dinucleotide-binding affinity and intracellular stability. We test in this work whether the evolutionarily recent neutral mutation R80H in the vicinity of S82 may alter the strong functional effects of S82 phosphorylation through electrostatic interactions. We show using biophysical and bioinformatic analyses that the reverse mutation H80R prevents the effects of S82D phosphorylation on hNQO1 by modulating the local stability. Consistently, in rat NQO1 (rNQO1) which contains R80, the effects of phosphorylation were milder, resembling the behaviour found in hNQO1 when this residue was humanized in rNQO1 (by the R80H mutation). Thus, apparently neutral and evolutionarily divergent mutations may determine the functional response of mammalian orthologues towards phosphorylation. © 2021 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Different phenotypic outcome due to site-specific phosphorylation in the cancer-associated NQO1 enzyme studied by phosphomimetic mutations

  • Pacheco-Garcia, Juan Luis
  • Anoz Carbonell, Ernesto
  • Loginov, Dmitry S.
  • Vankova, Pavla
  • Salido, Eduardo
  • Man, Petr
  • Medina, Milagros
  • Palomino-Morales, Rogelio
  • Pey, Angel L.
Protein phosphorylation is a common phenomenon in human flavoproteins although the functional consequences of this site-specific modification are largely unknown. Here, we evaluated the effects of site-specific phosphorylation (using phosphomimetic mutations at sites S40, S82 and T128) on multiple functional aspects as well as in the structural stability of the antioxidant and disease-associated human flavoprotein NQO1 using biophysical and biochemical methods. In vitro biophysical studies revealed effects of phosphorylation at different sites such as decreased binding affinity for FAD and structural stability of its binding site (S82), conformational stability (S40 and S82) and reduced catalytic efficiency and functional cooperativity (T128). Local stability measurements by H/D exchange in different ligation states provided structural insight into these effects. Transfection of eukaryotic cells showed that phosphorylation at sites S40 and S82 may reduce steady-levels of NQO1 protein by enhanced proteasome-induced degradation. We show that site-specific phosphorylation of human NQO1 may cause pleiotropic and counterintuitive effects on this multifunctional protein with potential implications for its relationships with human disease. Our approach allows to establish relationships between site-specific phosphorylation, functional and structural stability effects in vitro and inside cells paving the way for more detailed analyses of phosphorylation at the flavoproteome scale.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Counterintuitive structural and functional effects due to naturally occurring mutations targeting the active site of the disease-associated NQO1 enzyme*

  • Pacheco-García, Juan Luis
  • Anoz Carbonell, Ernesto
  • Loginov, Dmitry S.
  • Kavan, Daniel
  • Salido, Eduardo
  • Man, Petr
  • Medina, Milagros
  • Pey, Angel L.
Our knowledge on the genetic diversity of the human genome is exponentially growing. However, our capacity to establish genotype–phenotype correlations on a large scale requires a combination of detailed experimental and computational work. This is a remarkable task in human proteins which are typically multifunctional and structurally complex. In addition, mutations often prevent the determination of mutant high-resolution structures by X-ray crystallography. We have characterized here the effects of five mutations in the active site of the disease-associated NQO1 protein, which are found either in cancer cell lines or in massive exome sequencing analysis in human population. Using a combination of H/D exchange, rapid-flow enzyme kinetics, binding energetics and conformational stability, we show that mutations in both sets may cause counterintuitive functional effects that are explained well by their effects on local stability regarding different functional features. Importantly, mutations predicted to be highly deleterious (even those affecting the same protein residue) may cause mild to catastrophic effects on protein function. These functional effects are not well explained by current predictive bioinformatic tools and evolutionary models that account for site conservation and physicochemical changes upon mutation. Our study also reinforces the notion that naturally occurring mutations not identified as disease-associated can be highly deleterious. Our approach, combining protein biophysics and structural biology tools, is readily accessible to broadly increase our understanding of genotype–phenotype correlations and to improve predictive computational tools aimed at distinguishing disease-prone against neutral missense variants in the human genome.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Structural dynamics and functional cooperativity of human <scp>NQO1</scp> by ambient temperature serial crystallography and simulations

  • Grieco, Alice
  • Boneta, Sergio
  • Gavira, José A.
  • Pey, Angel L.
  • Basu, Shibom
  • Orlans, Julien
  • Sanctis, Daniele de
  • Medina, Milagros
  • Martin-Garcia, Jose Manuel
The human NQO1 (hNQO1) is a flavin adenine nucleotide (FAD)‐dependent oxidoreductase that catalyzes the two‐electron reduction of quinones to hydroquinones, being essential for the antioxidant defense system, stabilization of tumor suppressors, and activation of quinone‐based chemotherapeutics. Moreover, it is overexpressed in several tumors, which makes it an attractive cancer drug target. To decipher new structural insights into the flavin reductive half‐reaction of the catalytic mechanism of hNQO1, we have carried serial crystallography experiments at new ID29 beamline of the ESRF to determine, to the best of our knowledge, the first structure of the hNQO1 in complex with NADH. We have also performed molecular dynamics simulations of free hNQO1 and in complex with NADH. This is the first structural evidence that the hNQO1 functional cooperativity is driven by structural communication between the active sites through long‐range propagation of cooperative effects across the hNQO1 structure. Both structural results and MD simulations have supported that the binding of NADH significantly decreases protein dynamics and stabilizes hNQO1 especially at the dimer core and interface. Altogether, these results pave the way for future time‐resolved studies, both at x‐ray free‐electron lasers and synchrotrons, of the dynamics of hNQO1 upon binding to NADH as well as during the FAD cofactor reductive half‐reaction. This knowledge will allow us to reveal unprecedented structural information of the relevance of the dynamics during the catalytic function of hNQO1.